Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding
Xu, Yan, Schulman, Sam, Dowlatshahi, Dar, Holbrook, Anne M., Simpson, Christopher S., Shepherd, Lois E., Wells, Philip S., Giulivi, Antonio, Gomes, Tara, Mamdani, Muhammad, Frymire, Eliot, Khan, Shahriar, Johnson, Ana P.
Published in Thrombosis research (01.10.2019)
Published in Thrombosis research (01.10.2019)
Get full text
Journal Article
A phase III randomized trial of intermittent versus continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/ UK Intercontinental Trial CRUKE/01/013)
Crook, J. M., O'Callaghan, C. J., Ding, K., Duncan, G., Dearnaley, D. P., Higano, C. S., Horwitz, E. M., Frymire, E., Malone, S., Chin, J., Nabid, A., Warde, P. R., Corbett, T. B., Angyalfi, S., Goldenberg, S. L., Gospodarowicz, M. K., Saad, F., Logue, J. P., Schellhammer, P. F., Klotz, L.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Hypertension (HTN) in National Cancer Institute of Canada Clinical Trials Group study BR.24: A randomized, double-blind phase II trial of carboplatin (C) and paclitaxel (P) with either daily oral cediranib (CED), an inhibitor of vascular endothelial growth factor receptors, or placebo, in patients with advanced non-small cell lung cancer
Goodwin, R. A., Seymour, L., Ding, K., Gauthier, I., Le Maitre, A., Frymire, E., Arnold, A., Shepherd, F. A., Goss, G. D., Laurie, S. A.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article